Provenienza dei contatti di primo grado di Masayuki Aso
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
CellGenTech, Inc.
 CellGenTech, Inc. Pharmaceuticals: MajorHealth Technology CellGenTech, Inc. engages in the research and development of drugs for new gene therapy and regenerative medicine. It offers adipocyte-based medicine, technology for the development of gene/cell therapies. It also provides protein supplemental therapy solutions in the areas of hereditary diseases; orphan diseases; intractable diseases, such as lysosome and hemophilia; diabetics; arteriosclerotic diseases, and cancer or degenerative neuropathies. The company was founded by Masayuki Aso on October 20, 2003 and is headquartered in Chiba, Japan.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Masayuki Aso tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Anaeropharma Science, Inc.
 Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Major Banks | Corporate Officer/Principal | |
| Tokyo Institute of Technology | College/University | Graduate Degree | |
Watervein Partners KK
 Watervein Partners KK Investment ManagersFinance Watervein Partners KK (Watervein Partners) is an independent venture capital firm headquartered in Tokyo, Japan. The firm was founded in 2002 by Kuroishi Masafumi. | Investment Managers | Private Equity Investor | |
| NISSUI PHARMACEUTICAL CO., LTD. | Medical Specialties | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
| Giappone | 5 |
| Stati Uniti | 2 |
Settori
| Health Technology | 3 |
| Finance | 3 |
| Consumer Services | 2 |
Posizioni
| Director/Board Member | 6 |
| Corporate Officer/Principal | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
| Private Equity Investor | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Tetsuya Mishima | 5 |
| Yoshitaka Tanaka | 2 |
| Masami Tanio | 1 |
| Seiji Tanaka | 1 |
| Takahiro Shimada | 1 |
- Borsa valori
- Insiders
- Masayuki Aso
- Connessioni Società
